This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: Johns Hopkins University, Lieber Institute, Inc.. Active years: 2026.
Company Filing History:
1 out of 3,795 
1 out of 9 
Years Active: 2026
Title: Tony Dorado: Innovator in RNA Polymerase Inhibition
Introduction
Tony Dorado is a notable inventor based in Baltimore, MD (US). He has made significant contributions to the field of biochemistry, particularly in the development of compounds that inhibit RNA polymerase. His work is crucial for advancing treatments for diseases where RNA polymerase activity plays a detrimental role.
Latest Patents
Tony Dorado holds 1 patent for his innovative work on compounds that inhibit RNA polymerase I (Pol I). This patent features chemical entities, including compounds or their pharmaceutically acceptable salts, hydrates, cocrystals, or drug combinations. These entities are designed to treat conditions where excessive Pol I activity contributes to the pathology of diseases such as cancer. The patent also includes compositions and methods for using and making these compounds.
Career Highlights
Throughout his career, Tony has worked with prestigious institutions, including Johns Hopkins University and the Lieber Institute, Inc. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Tony Dorado has collaborated with Hester Hui Liu, enhancing the scope and impact of his research. Their partnership exemplifies the importance of teamwork in scientific innovation.
Conclusion
Tony Dorado's work in developing RNA polymerase inhibitors represents a significant advancement in medical research. His contributions are vital for the ongoing fight against diseases like cancer, showcasing the importance of innovation in healthcare.